Calton & Associates’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Calton & Associates’s Portfolio IBDQ Stock Details IBDQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13,538	Closed	-$341K	–	465
2025 Q3	$341K	Buy	13,538 +629	+5%	+$15.8K	0.05%	298
2025 Q2	$325K	Sell	12,909 -1,248	-9%	-$31.3K	0.06%	274
2025 Q1	$356K	Buy	+14,157	New	+$355K	0.08%	220
2024 Q4	–	Sell	-8,928	Closed	-$224K	–	229
2024 Q3	$224K	Buy	+8,928	New	+$223K	0.09%	203

Other funds holding IBDQ

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

Balentine LLC Atlanta, Georgia $2.48B AUM 17.44% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Calton & Associates's IBDQ Position: Q4 2025 in Review

Calton & Associates sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 13,538 shares — an estimated $341K sold.

Calton & Associates first reported a position in IBDQ in Q3 2024 and held it in 4 quarters. The position peaked at $356K in Q1 2025. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

Calton & Associates reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
Calton & Associates sold 13,538 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $341K.
Calton & Associates first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q3 2024 and held it in 4 quarters.
Calton & Associates's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $356K in Q1 2025.
3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on Calton & Associates's 13F filing for Q4 2025, filed 10 Feb 2026.